Dysregulation of CD44 is associated with multiple cancers including lung cancer [35], breast cancer [36], osteosarcoma [37] colorectal cancer [38] and glioma [39] etc. Moreover, a recent report has shown that depletion of CD44 in GBM cells induces senescence and inhibits growth and stemness [40]. This evidence concerns the gene CD44 and osteosarcoma.